Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

s were consistent with the intelligence community's previous assessments about Tehran's intentions when it comes to interference in the 2020 race." Amanda Schoch said in a statement to CNN, "As NCSC Director Bill Evanina said on August 7th, the IC assesses 'that Iran seeks to undermine U.S. democratic instit

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

ts were consistent with the intelligence community's previous assessments about Tehran's intentions when it comes to interference in the 2020 race." Amanda Schoch said in a statement to EFTA00136943 CNN, "As NCSC Director Bill Evanina said on August 7th, the IC assesses `that Iran seeks to undermine U.S. de

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

nt with the intelligence community's previous assessments about Tehran's intentions when it EFTA00148449 comes to interference in the 2020 race." Amanda Schoch said in a statement to CNN, "As NCSC Director Bill Evanina said on August 7th, the IC assesses 'that Iran seeks to undermine U.S. democratic instit